More NewsRead More
BioDelivery Sciences Announces Randomization Target Reached in Clinical Trial of Clonidine Topical Gel for the Treatment of Painful Diabetic Neuropathy
August 04, 2016
BioDelivery Sciences to Host Conference Call and Webcast of Second Quarter 2016 Results on Tuesday, August 9
August 01, 2016
BioDelivery Systems' BUNOVAIL receives preferred status
July 12, 2016
Biomerica Adds Dr. Mark Sirgo to Board of Directors
July 18, 2016
BioDelivery Sciences Announces the Securing of Preferred Formulary Status for BUNAVAIL on a Significant Managed Care Plan
July 11, 2016
BRIEF-Biodelivery Sciences Q2 loss per share $0.31
August 09, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here